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New findings say ‘never take a TB  
cure for granted’
Stellenbosch University (SU) research find-
ings published online in Nature Medicine 
in September[1] show that that 86% of HIV-
negative ‘cured’ tuberculosis (TB) patients 
examined still had actively inflamed lung 
lesions, while a third of them had new or 
exacerbated lesions.
The surprising findings highlight how 
important it is for healthcare workers to retain 
a high index of suspicion even if a smear test 
at the end of a TB treatment course is negative, 
Dr Stephanus Malherbe, of SU’s Immunology 
Research Group, told Izindaba.
‘We’re working on better tools to monitor 
treatment response, but this [study of 99 HIV-
negative, TB-diagnosed and ‘cured’ patients] 
shows that TB almost goes back into a latent 
subclinical phase after treatment,’ he said. 
The findings would be a catalyst for further 
tests around immune therapy and immune 
modulation, but they already emphasised 
the importance of improved counselling 
and advanced testing. Advanced imaging 
accurately showing the sites of inflammation 
during and after treatment revealed that only 
14% of the study group had no remaining 
inflammation in the lung after treatment 
was completed. SU worked in collaboration 
with the Catalysis Foundation of Health, 
Rutgers New Jersey Medical School, Stanford 
University School of Medicine and the US 
National Institutes of Health.
Malherbe said the findings point to the 
crucial role of the body’s immune response 
in suppressing or eradicating any residual 
live bacteria after treatment. Any treatment 
aimed at boosting the immune response 
should improve outcomes. Instead of ‘patting 
a patient on the back’ once their smear 
was negative, healthcare workers who saw 
anything vaguely suspicious should send 
them for an X-ray and arrange a follow-
up appointment, counselling them to eat 
healthily and to avoid smoking or drinking.
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